-
1
-
-
85026175613
-
-
Rorke LB. Pathology of brain and spinal cord tumors. In: Choux M, Di Rocco C, Hockley AD, Walker ML, eds. Pediatric Neurosurgery. London: Churchill Livingstone; 1999:396.
-
Rorke LB. Pathology of brain and spinal cord tumors. In: Choux M, Di Rocco C, Hockley AD, Walker ML, eds. Pediatric Neurosurgery. London: Churchill Livingstone; 1999:396.
-
-
-
-
2
-
-
85026178298
-
-
Caldarelli M, Pezzota S. Optic pathway and hypothalamic tumors. In: Choux M, Di Rocco C, Hockley AD, Walker ML, eds. Pediatric Neurosurgery. London: Churchill Livingstone; 1999:509.
-
Caldarelli M, Pezzota S. Optic pathway and hypothalamic tumors. In: Choux M, Di Rocco C, Hockley AD, Walker ML, eds. Pediatric Neurosurgery. London: Churchill Livingstone; 1999:509.
-
-
-
-
4
-
-
0033038672
-
Nonalcoholic fatty liver disease: a spectrum of clinical and pathologic severity.
-
Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathologic severity. Gastroenterology 1999;116:1413-9.
-
(1999)
Gastroenterology
, vol.116
, pp. 1413-9
-
-
Matteoni, C.A.1
Younossi, Z.M.2
Gramlich, T.3
Boparai, N.4
Liu, Y.C.5
McCullough, A.J.6
-
6
-
-
17744393643
-
The risks of percutaneous liver biopsy.
-
Falck-Ytter Y, McCullough AJ. The risks of percutaneous liver biopsy. Hepatology 2001;33:764.
-
(2001)
Hepatology
, vol.33
, pp. 764
-
-
Falck-Ytter, Y.1
McCullough, A.J.2
-
7
-
-
0028126082
-
Development of complete liver cirrhosis in hyperphagia-induced fatty liver in German.
-
Basenau D, Stehphani U and Fischer G. Development of complete liver cirrhosis in hyperphagia-induced fatty liver [in German]. Klin Pediatr 1994;206:62-4.
-
(1994)
Klin Pediatr
, vol.206
, pp. 62-4
-
-
Basenau, D.1
Stehphani U and Fischer, G.2
-
8
-
-
0031937707
-
Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite.
-
Roth C, Wilken B, Hanefeld F, Schröter W, Leonhardt U. Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. Eur J Endocrinol 1998;138:89-91.
-
(1998)
Eur J Endocrinol
, vol.138
, pp. 89-91
-
-
Roth, C.1
Wilken, B.2
Hanefeld, F.3
Schroter, W.4
Leonhardt, U.5
-
9
-
-
0035078599
-
Animal models of steatosis.
-
Koteish A, Diehl AM. Animal models of steatosis. Sem Liv Dis 2001;21:89-104.
-
(2001)
Sem Liv Dis
, vol.21
, pp. 89-104
-
-
Koteish, A.1
Diehl, A.M.2
-
10
-
-
0347392124
-
Leptin is an independent marker of liver fibrosis in humans with nonalcoholic fatty liver disease abstract.
-
Alba LM, Petrovic L, Lindor KD, Talwalkar JA, Angulo P. Leptin is an independent marker of liver fibrosis in humans with nonalcoholic fatty liver disease [abstract]. Hepatology 2002;36:296A.
-
(2002)
Hepatology
, vol.36
, pp. 296A
-
-
Alba, L.M.1
Petrovic, L.2
Lindor, K.D.3
Talwalkar, J.A.4
Angulo, P.5
-
11
-
-
0034068984
-
Non-alcoholic steatohepatitis: association with obesity and insulin resistance and influence of weight loss.
-
Luyckx FH, Lefebvre PJ, Scheen AJ. Non-alcoholic steatohepatitis: association with obesity and insulin resistance and influence of weight loss. Diab Metab 2000;26:98-106.
-
(2000)
Diab Metab
, vol.26
, pp. 98-106
-
-
Luyckx, F.H.1
Lefebvre, P.J.2
Scheen, A.J.3
-
12
-
-
0035883890
-
Metformin in non-alcoholic steatohepatitis.
-
Marchesini G, Brizi M, Bianchi G, Tomassetti S, Zoli M, Melchionda N. Metformin in non-alcoholic steatohepatitis. Lancet 2001;358:893-4.
-
(2001)
Lancet
, vol.358
, pp. 893-4
-
-
Marchesini, G.1
Brizi, M.2
Bianchi, G.3
Tomassetti, S.4
Zoli, M.5
Melchionda, N.6
|